Sixth, we excluded the possibility that hypoxic NESP55 immunoreactivity is a general response to hypoxia by testing some other pediatric tumors of central nervous system origin and examining NESP55 expression in two non-neuroblastoma brain tumor-derived cell lines. This evidence concerns the gene GNAS and neuroblastoma.